Key facts
- Arcuro Medical’s last known valuation is $4.7M (Apr 2025).
- It has raised $1.2M; the latest was Later Stage VC ($550K) in Apr 2025.
- Notable investors include Consensus Business Group, Varana Capital, Xenia Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Arcuro Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Arcuro Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arcuro Medical
Developer of an all-suture meniscus repair system designed for the anatomic repair of the meniscus. The company's system consists of a knotless, all-suture implant and innovative delivery system for a meniscus repair, which is performed inside the joint space using suture material, enabling medical practitioners to perform treatment with safe, reliable, and effective meniscus repairs.
- Sector
- Healthcare
- HQ
- Misgav, Israel
- Founded
- 2013
- Employees
- 11
- Website
- arcuromedical.com/
- Ownership
- Privately Held (backing)
Arcuro Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arcuro Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arcuro Medical in its N-PORT filings yet. We sweep new filings monthly.